Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Summary
Brief summary The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).
Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
270
Start Date
2024-10-10
Completion Date
2029-01
Last Updated
2026-03-06
Healthy Volunteers
Yes
Conditions
Interventions
XmAb942
Antibody
Placebo
Placebo
Locations (40)
Xencor Investigative Site
Scottsdale, Arizona, United States
Xencor Investigative Site
Bradenton, Florida, United States
Xencor Investigative Site
Jacksonville, Florida, United States
Xencor Investigative Site
Kissimmee, Florida, United States
Xencor Investigative Site
Tampa, Florida, United States
Xencor Investigative Site
Raleigh, North Carolina, United States
Xencor Investigative Site
Denton, Texas, United States
Xencor Investigative Site
Houston, Texas, United States
Xencor Investigative Site
Kingwood, Texas, United States
Xencor Investigative Site
San Antonio, Texas, United States
Xencor Investigative Site
Wollongong, New South Wales, Australia
Xencor Investigative Site
South Brisbane, Queensland, Australia
Xencor Investigative Site
Joondalup, Western Australia, Australia
Xencor Investigative Site
Nedlands, Western Australia, Australia
Xencor Investigative Site
Sofia, Bulgaria
Xencor Investigative Site
Vancouver, British Columbia, Canada
Xencor Investigative Site
London, Ontario, Canada
Xencor Investigative Site
Scarborough Village, Ontario, Canada
Xencor Investigative Site
Zagreb, Croatia
Xencor Investigative Site
Tbilisi, Georgia
Xencor Investigative Site
Budapest, Hungary
Xencor Investigative Site
Chisinau, Moldova
Xencor Investigative Site
Wroclaw, Lower Silesian Voivodeship, Poland
Xencor Investigative Site
Sopot, Pomeranian Voivodeship, Poland
Xencor Investigative Site
Bydgoszcz, Poland
Xencor Investigative Site
Katowice, Poland
Xencor Investigative Site
Staszów, Poland
Xencor Investigative Site
Szczecin, Poland
Xencor Investigative Site
Warsaw, Poland
Xencor Investigative Site
Bucharest, District 1, Romania
Xencor Investigative Site
Cluj-Napoca, Romania
Xencor Investigative Site
Lutsk, Volyn Oblast, Ukraine
Xencor Investigative Site
Ivano-Frankivsk, Ukraine
Xencor Investigative Site
Kyiv, Ukraine
Xencor Investigative Site
Kyiv, Ukraine
Xencor Investigative Site
Lviv, Ukraine
Xencor Investigative Site
Lviv, Ukraine
Xencor Investigative Site
Uzhhorod, Ukraine
Xencor Investigative Site
Vinnytsia, Ukraine
Xencor Investigative Site
Zhytomyr, Ukraine